Verano Moves to Federally Register Medical Cannabis Operations After Rescheduling
Event summary
- Verano submitted DEA registration applications for its state-licensed medical cannabis operations on May 13, 2026.
- The move follows the federal rescheduling of medical marijuana to Schedule III.
- Verano operates 162 dispensaries and 14 production facilities across 13 states.
- Medical cannabis sales account for a majority of Verano's retail business.
The big picture
Verano's DEA registration applications mark a critical step in the cannabis industry's transition from state-level legality to federal recognition. The rescheduling of medical marijuana to Schedule III creates a new regulatory pathway for operators like Verano to expand their medical focus, potentially unlocking research collaborations and commercial partnerships previously constrained by federal prohibition. The move underscores the strategic importance of medical cannabis in Verano's business model, which accounts for the majority of its retail sales.
What we're watching
- Regulatory Execution
- How quickly the DEA processes Verano's applications will determine the pace of federal compliance for medical cannabis operators.
- Commercial Potential
- Whether Schedule III designation unlocks significant research and commercial opportunities for Verano's medical cannabis portfolio.
- Industry Precedent
- The extent to which Verano's move sets a template for other multi-state cannabis operators seeking federal registration.